Signal active
Contact Information
Social
Primary Organization
1986
65
17
31
10001+
Biotechnology, Medical
Bio
Robert Hershberg (M.D., Ph.D.) Chief Executive Officer at VentiRX Pharmaceuticals.Dr. Robert Hershberg is a founder of VentiRx Pharmaceuticals and serves as Chief Executive Officer and member of the Board of Directors. VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer. The Company's initial focus is developing novel small molecule product candidates targeting Toll-like receptor 8 (TLR8) for oncology and allergy.
Prior to VentiRx, Dr. Hershberg served as Senior Vice President and Chief Medical Officer at Dendreon Corporation, developing immunotherapy approaches for cancer. In this capacity, Dr. Hershberg led the Clinical, Regulatory, and Biometrics groups, focusing on the development of Provenge™ in metastatic prostate cancer.
Prior to joining Dendreon, Dr. Hershberg was the Vice President of Medical Genetics at Corixa Corporation (subsequently acquired by GSK). He led a research group focused on innate immunity and inflammatory disease, with a particular emphasis on Toll-like receptors (TLRs), and was an active member of the clinical development team for various products.
Prior to joining Corixa, Dr. Hershberg was an Assistant Professor at Harvard Medical School and an Associate Physician at the Brigham and Women's Hospital in Boston, Massachusetts.He completed his Undergraduate Degree in Molecular Biology and M.D. at UCLA, and his Ph.D. in Biology at the Salk Institute.Dr. Hershberg is clinically-boarded in Medical Genetics, and holds current clinical and research faculty positions at the University of Washington School of Medicine.
Location
Seattle, Washington, United States, North America
Jobs history
4
Cajal Neuroscience
Board Member
2022 - Current
HilleVax
Co-Founder, CEO, and Chairman of the Board
2021 - Current
Cajal Neuroscience
Co-Founder
Invalid date - Current
Ozette Technologies
Scientific Advisor
Invalid date - Current
Educations
2
University of California, Los Angeles
Medicine/Biology
University of California, Los Angeles
Medicine/Biology
Profile Resume
Robert M. Hershberg is the Executive Vice President, Head of Business Development and Global Alliances at Celgene, based in United States, North America. With a background in Biotechnology, Robert M. Hershberg has a rich history of leadership and innovation.Robert M. Hershberg studied unknown Medicine/Biology at University of California, Los Angeles. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.